UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell

Cancer immunology research, 2019-08, Vol.7 (8), p.1258-1266

2019

Volltextzugriff (PDF)

Single-Institution Experience in 3D MRI-Based Brachytherapy for Cervical Cancer for 239 Women: Can Dose Overcome Poor Response?

International journal of radiation oncology, biology, physics, 2019-05, Vol.104 (1), p.157-164

2019

Volltextzugriff (PDF)

Financial Burden in Patients With Head and Neck Cancer Treated With Radiation Therapy: An Underaddressed Toxicity

International journal of radiation oncology, biology, physics, 2023-05, Vol.116 (1), p.154-156

2023

Volltextzugriff (PDF)

Pharmacologic inhibition of ataxia telangiectasia and Rad3‐related (ATR) in the treatment of head and neck squamous cell carcinoma

Molecular carcinogenesis, 2022-02, Vol.61 (2), p.225-238

2022

Volltextzugriff (PDF)

ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation

The Journal of clinical investigation, 2018-08, Vol.128 (9), p.3926-3940

2018

Volltextzugriff (PDF)

Pembrolizumab, radiotherapy, and chemotherapy in neoadjuvant treatment of malignant esophago-gastric diseases (PROCEED): Assessment of pathologic response and toxicity in a prospective, phase II single-arm trial

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4062-4062

2023

Volltextzugriff (PDF)

Pre-operative Radiation and Immunotherapy in the Treatment of Non-metastatic Breast Cancer

Current breast cancer reports, 2023-09, Vol.15 (3), p.213-221

2023

Volltextzugriff (PDF)

A Window to Internet-based Information Seeking of US Fourth-Year Medical Students: Are Radiation Oncology Residency Program Websites Comprehensive?

International journal of radiation oncology, biology, physics, 2018-07, Vol.101 (4), p.789-791

2018

Volltextzugriff (PDF)

Declining brachytherapy utilization for high-risk prostate cancer—Can clinical pathways reverse the trend?

Brachytherapy, 2018-11, Vol.17 (6), p.895-898

2018

Volltextzugriff (PDF)

ATR kinase inhibitor AZD6738 potentiates CD8^sup +^ T cell–dependent antitumor activity following radiation

The Journal of clinical investigation, 2018-09, Vol.128 (9), p.3926-3940

2018

Volltextzugriff (PDF)

ATR kinase inhibitor AZD6738 potentiates [CD8.sup.+] T cell-dependent antitumor activity following radiation.(RESEARCH ARTICLE)

The Journal of clinical investigation, 2018-09, Vol.128 (9), p.3926

2018

Volltextzugriff (PDF)

Standardization of radiation therapy dose for locally advanced non-small cell lung cancer through changes to a lung cancer clinical pathway in a large, integrated comprehensive cancer center network

Practical Radiation Oncology, 2017-11, Vol.7 (6), p.e551-e557

2017

Volltextzugriff (PDF)

IRF1 inhibits antitumor immunity through the upregulation of PD-L1 in the tumor cell: Tumor promoting activity of IRF1

Cancer immunology research, 2019-06

2019

Volltextzugriff (PDF)

Management of Metastic Liver Cancer

Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e, 2024, p.347-385

2024

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(13)
Buchkapitel
(1)

Sprache

Englisch
(14)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Oncology
(8)
Radiology, Nuclear Medicine & Medical Imaging
(5)
Humans
(3)
Immunotherapy
(3)
Cancer Research
(2)
Chemotherapy
(2)
Deoxyribonucleic Acid
(2)
Dna
(2)
Dna Damage
(2)
Head & Neck Cancer
(2)
Male
(2)
Radiation
(2)
Radiation Therapy
(2)
Squamous Cell Carcinoma
(2)
Abscopal
(1)
Adjuvant Chemotherapy
(1)
Adjuvant Treatment
(1)
Aged
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell

Single-Institution Experience in 3D MRI-Based Brachytherapy for Cervical Cancer for 239 Women: Can Dose Overcome Poor Response?

Financial Burden in Patients With Head and Neck Cancer Treated With Radiation Therapy: An Underaddressed Toxicity

Pharmacologic inhibition of ataxia telangiectasia and Rad3‐related (ATR) in the treatment of head and neck squamous cell carcinoma

ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation

Pembrolizumab, radiotherapy, and chemotherapy in neoadjuvant treatment of malignant esophago-gastric diseases (PROCEED): Assessment of pathologic response and toxicity in a prospective, phase II single-arm trial

Pre-operative Radiation and Immunotherapy in the Treatment of Non-metastatic Breast Cancer

A Window to Internet-based Information Seeking of US Fourth-Year Medical Students: Are Radiation Oncology Residency Program Websites Comprehensive?

Declining brachytherapy utilization for high-risk prostate cancer—Can clinical pathways reverse the trend?

ATR kinase inhibitor AZD6738 potentiates CD8^sup +^ T cell–dependent antitumor activity following radiation

ATR kinase inhibitor AZD6738 potentiates [CD8.sup.+] T cell-dependent antitumor activity following radiation.(RESEARCH ARTICLE)

Standardization of radiation therapy dose for locally advanced non-small cell lung cancer through changes to a lung cancer clinical pathway in a large, integrated comprehensive cancer center network

IRF1 inhibits antitumor immunity through the upregulation of PD-L1 in the tumor cell: Tumor promoting activity of IRF1

Management of Metastic Liver Cancer

Suchergebnisse filtern